Most Read This Week
- Weight, Cardiometabolic, and Hormonal Outcomes of Whole-Food, Plant-Based Diet in Patients With Metastatic Breast Cancer
- Real-World Treatment Patterns and Survival Outcomes in Patients With De Novo HER2+ Metastatic Breast Cancer Prior to and After 2013
- Association of Neutrophil-to-Lymphocyte Ratio and Absolute Lymphocyte Count With Clinical Outcomes in Patients With Advanced Breast Cancer
- Outcomes in Patients With Metastatic TNBC and Their Association With HER2 and Trop-2 Expression Status
- Mutational Analysis of ctDNA in Patients With ER+/HER2− Advanced Breast Cancer Receiving Palbociclib
Recently Updated
- Patient Advocate–Led Survey Results Regarding MBC Treatment Side Effects and Impact on Quality of Life
- Impact of Initial Tumor Response on Survival Outcomes in Patients With HER2+ Advanced Breast Cancer Treated With Docetaxel, Trastuzumab, and Pertuzumab
- Mutational Analysis of ctDNA in Patients With ER+/HER2− Advanced Breast Cancer Receiving Palbociclib
- Outcomes in Patients With Metastatic TNBC and Their Association With HER2 and Trop-2 Expression Status
- Weight, Cardiometabolic, and Hormonal Outcomes of Whole-Food, Plant-Based Diet in Patients With Metastatic Breast Cancer